Company intelligence / Profile preview

Orchid Finance

Gurgaon, Haryana, India

Ownership: Private
Development stage: Other

Overview

Orchid Pharma is a vertically integrated pharmaceutical manufacturer specializing in the development and supply of cephalosporin antibiotics, APIs, and finished dosage forms, with broad regulatory approvals and international distribution. Latest clinical update reports global rights acquisition for enmetazobactam and ongoing strategic R&D projects; company is financially stable and expanding manufacturing capabilities

Therapeutic areas: ImmunologyInfectious Diseases
Modalities: Small moleculeBiologicAntibiotic
Industry: Biotech

Partnerships

Global licensing deal for "Enmetazobactam"Strategic distribution and manufacturing alliances globally

Beyond the preview

Go deeper on Orchid Finance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orchid Finance.

Explore the full profile